Delpor, Inc.
- Biotech or pharma, therapeutic R&D
Note: We are not interested in meeting with CROs, CMOs, and Service Providers.
Delpor is a clinical stage biopharmaceutical company that develops new therapeutic products in CNS/Psychiatric Conditions (including schizophrenia, Opioid Use Disorder, Spasticity, and Parkinson’s), Chronic Pain (including Fibromyalgia and Complex Regional Pain Syndrome), Autoimmune Diseases (including MS, Crohn’s, RA, and Lupus), and other conditions.